Atul A. Kalanuria, MD, FACP, MHCI

Associate Scholar

  •  Assistant Professor of Neurology, Neurosurgery, Anesthesia and Critical Care | University of Pennsylvania
  •  India | United States
  •   Brain and Spinal Diseases | Neurology

Languages: English, Hindi, Marathi

Bio statement

I am a neuro-intensivist at Penn, and I specialize in the management of acute brain and spine diseases. The outcome of acute neurological diseases such as stroke and traumatic brain and spine injuries depends heavily on the care given within the first few hours. The exploration of the scope of practice and ability of providers to care for such patients in resource scare environments is a matter of great importance and personal interest. Many of these injuries can be salvaged with meager resources and modification of existing practices. As a neurointensivist at Penn medicine, my role is to promote brain healing while identifying and treating injury. My training in innovation equips me with tools to improve healthcare.

Brought up in India, I am able to appreciate the technological, logistical and operational insufficiencies there. There is a growing need for acute neurological and neurosurgical care in most parts of India and my hope is that I will be able to accomplish my goal of forging partnerships in my home country.

Recent Global Health Projects

Mentoring: I have mentored a neuro-intensivist in the Philippines though the Neurocritical Care Society. My role was to help my mentee establish a fully functional neurocritical care unit in Manila, Philippines. This experience has allowed me to understand the healthcare system, payment models and resources available in a developing Asian country. This association had a duration of 18 months. I have also mentored to a neurology resident from Ethiopia who is training in the US thought the same Society. Through my discussion with him I got a glimpse of the healthcare system in an African nation with very meager resources and huge gaps in care. This association lasted 12 months.

Last Updated: 28 February 2022